Edges in Network
| Network | GSE16446_egf1520 - GSE16446 - SiGN-BN HC+Bootstrap |
| Network Description | Predicting the efficacy of anthracyclines in breast cancer (BC) patients: The results of the TOP trial |
| Node | B3GNT3 |
| Upstream (Parents) |
|---|
| (<<) ABLIM1 → B3GNT3 |
| (<<) APC2 → B3GNT3 |
| (<<) CAMKK1 → B3GNT3 |
| (<<) CASP2 → B3GNT3 |
| (<<) CAV3 → B3GNT3 |
| (<<) CRTC1 → B3GNT3 |
| (<<) DNM1L → B3GNT3 |
| (<<) DSCAM → B3GNT3 |
| (<<) FA2H → B3GNT3 |
| (<<) FOXA2 → B3GNT3 |
| (<<) GLTPD1 → B3GNT3 |
| (<<) GRIN2D → B3GNT3 |
| (<<) GSK3A → B3GNT3 |
| (<<) GSTK1 → B3GNT3 |
| (<<) LRP6 → B3GNT3 |
| (<<) MAP3K10 → B3GNT3 |
| (<<) MGC45922 → B3GNT3 |
| (<<) MMP25 → B3GNT3 |
| (<<) NEUROG1 → B3GNT3 |
| (<<) NRAS → B3GNT3 |
| (<<) PRSS22 → B3GNT3 |
| (<<) RCBTB1 → B3GNT3 |
| (<<) SPDEF → B3GNT3 |
| (<<) UCA1 → B3GNT3 |
| Downstream (Children) |
|---|
| B3GNT3 → ALPPL2 (>>) |
| B3GNT3 → CALML5 (>>) |
| B3GNT3 → CAPRIN2 (>>) |
| B3GNT3 → CDC42EP5 (>>) |
| B3GNT3 → CKB (>>) |
| B3GNT3 → EPHA2 (>>) |
| B3GNT3 → FUT2 (>>) |
| B3GNT3 → HSD17B2 (>>) |
| B3GNT3 → KCNN4 (>>) |
| B3GNT3 → MLXIPL (>>) |
| B3GNT3 → PLA2G3 (>>) |
| B3GNT3 → SGCA (>>) |
| B3GNT3 → SHB (>>) |
| B3GNT3 → SLC5A1 (>>) |
| B3GNT3 → TUBA8 (>>) |
